ROSATOM helps Kyrgyzstan develop nuclear medicine
An expert commission of representatives of the Ministry of Health of the Kyrgyz Republic and ROSATOM completed the key stage of the roadmap for the project to create a new department of radionuclide diagnostics for the treatment of patients with oncological and other socially significant diseases at the National Center for Oncology and Hematology (NCОН) in Bishkek.
The parties are developing interaction within the framework of the IAEA technical cooperation program, which aims to develop advanced nuclear medicine technologies in Kyrgyzstan.
The working group, consisting of NCОН employees and representatives of ROSATOM, implemented a set of measures necessary to conduct a sanitary and epidemiological examination of the department of single-photon emission computed tomography (SPECT) and obtain a license from the regulatory authorities of the Kyrgyz Republic for compliance of the project with radiation safety requirements. ROSATOM also delivered a technetium-99m GT-4K generator to NCОН free of charge in order to train personnel, assess the effectiveness of the national infrastructure, and also to enable a medical institution to obtain a license to use radioisotope products.
The delegation of the Russian nuclear industry provided expert support to the NCОН staff during the technical examination of the SPECT department by authorized representatives of the Department for Disease Prevention and State Sanitary and Epidemiological Surveillance of the Ministry of Health of the Kyrgyz Republic and the Department of State Regulation in the Sphere of Environmental Protection and Ecological Safety of the Ministry of Natural Resources, Ecology and Technical supervision of Kyrgyzstan. The next step is to obtain a license from the Kyrgyz Republic regulatory authorities for the project's compliance with radiation safety requirements, and for the use of radioisotope products.
"We are happy to provide full support to our Kyrgyz partners in preparation for the commissioning of the new radionuclide diagnostics department. This project is vital for the development of atomedics in the Republic of Kyrgyzstan and our further strategic cooperation. We donated the technetium generator to our Kyrgyz colleagues for training doctors. In the future, ROSATOM is ready to fully meet the needs of the Kyrgyz Republic in technetium-99m generators," said Igor Obrubov, Director General of Rusatom Healthcare, the ROSATOM's division.
In June 2023, ROSATOM and the Republic of Kyrgyzstan signed a Memorandum of Cooperation in the field of non-energy application of nuclear technologies in healthcare. The parties agreed to jointly develop high-tech medical projects in Kyrgyzstan. In particular, this involves the creation of a radiopharmaceutical pharmacy, a center for molecular imaging and a center for targeted therapy and theranostics based on the National Center for Oncology and Hematology (NCOH), where advanced methods of diagnostics and treatment of oncological and other diseases will be applied. The parties are already cooperating in issues of equipment supplies and commissioning of the single-photon emission computed tomography department established under the IAEA technical cooperation program. Russian specialists assist Kyrgyz colleagues in the preparation of the necessary authorization documentation.
About 2.5 million of diagnostic and therapeutic procedures in Russia and abroad can be performed with ROSATOM radioisotope medical products. Diagnostics with the use of radiopharmaceutical products enables early detection of any diseases and timely commencement of therapy.
Technetium-99m is the most demanded isotope in nuclear medicine. Technetium-99m generators are used for diagnostics in oncologic, cardiologic, neuroendocrine and other diseases.